Plasma levels of interleukin‐6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Objective: We investigated the plasma levels of interleukin (IL)‐6 and 5‐HTT polymorphisms in patients with major depressive disorder (MDD). This is the first report, to our knowledge, of an investigation into the association between 5‐HTT gene polymorphism, plasma IL‐6 levels, and responses to selective serotonin reuptake inhibitors (SSRIs) in Japanese patients with MDD. Method: One‐hundred and eighteen patients (51 male, 67 female) who met the DSM‐IV criteria for MDD were enrolled. Their ages ranged from 24 to 78 (mean ± SD = 44 ± 12) years. The patients were treated with SSRIs (paroxetine in 66 cases, sertraline in 42 cases) for 8 weeks. Results: The plasma levels of IL‐6 were significantly higher in the SSRI responders than in the nonresponders (p = 0.0328), and the changes in plasma IL‐6 levels correlated significantly with the changes in severity of depressive state (p = .0.007). No difference was found in baseline and the changes in plasma IL‐6 levels between the patients with a 5‐HTT gene (5‐HTTLPR) L‐carrier and those with S/S. Conclusion: These results suggest that the plasma levels of IL‐6 reflect the severity of MDD and that plasma IL‐6 levels might be another biological‐state marker for the depressive state. In addition, the 5‐HTTLPR polymorphism might be independent of plasma IL‐6 levels. Copyright © 2013 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579 · cited 1×
“…hormone activity at limbic sites, monoamine utilization, the release of oxidative stress, apoptotic pathways, and kinase signaling (Mastorakos et al., 1994; Chrousos, 1995; Dentino et al., 1999; Hayley et al., 2005), all of which have very close relationships to the pathophysiology of depression.”
BackgroundMicroglia as a source and target of cytokines
Hanisch, U. (2002) · Glia · doi:10.1002/glia.10161 · Cited by 1,645 · cited 1×
“Microglias are the primary central reservoirs of pro-inflammatory cytokines, and they act as antigen-presenting cells in the brain (Hanisch, 2002).”
BackgroundHannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784
Passage of cytokines across the blood–brain barrier
Banks, W. A., Kastin, A. J., & Broadwell, R. D. (1996) · Neuroimmunomodulation · doi:10.1159/000097202 · Cited by 778
Hayley, S., Poulter, M. O., Merali, Z., & Anisman, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.051 · Cited by 324
Mastorakos, G., Weber, J. S., Magiakou, M. A., Gunn, H., & Chrousos, G. P. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962300 · Cited by 290 · cited 1×
“In particular, it was suggested that IL-6 is involved in multiple physiological systems including the hypothalamic–pituitary–adrenal axis and in corticotrophinreleasing hormone activity at limbic sites, monoamine utilization, the release of oxidative stress, apoptotic pathways, and kinase signaling (Mastorakos et al.,…”
BackgroundDentino, A. N., Pieper, C. F., Rao, K. M. K., Currie, M. S., Harris, T., Blazer, D. G., & Cohen, H. J. (1999) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1999.tb01894.x · Cited by 287 · cited 1×
“…hormone activity at limbic sites, monoamine utilization, the release of oxidative stress, apoptotic pathways, and kinase signaling (Mastorakos et al., 1994; Chrousos, 1995; Dentino et al., 1999; Hayley et al., 2005), all of which have very close relationships to the pathophysiology of depression.”
BackgroundHiles, S. A., Baker, A. L., de Malmanche, T., & Attia, J. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.06.001 · Cited by 274
Bull, S. J., Huezo-Diaz, P., Binder, E. B., Cubells, J. F., Ranjith, G., Maddock, C., Miyazaki, C., Alexander, N., Hotopf, M., Cleare, A. J., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.48 · Cited by 228 · cited 1×
“In contrast, Bull et al. (2009) reported that functional polymorphism in the IL-6 gene and 5-HTT gene (5-HTTLPR) is a protective factor against the development of depression.”
BackgroundDhabhar, F. S., Burke, H. M., Epel, E. S., Mellon, S. H., Rosser, R., Reus, V. I., & Wolkowitz, O. M. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.05.010 · Cited by 225
Kemp, A. H., Gordon, E., Rush, A. J., & Williams, L. M. (2008) · CNS Spectrums · doi:10.1017/s1092852900017120 · Cited by 170
Cited by
Inflammation and clinical response to treatment in depression: A meta-analysis
Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.007 · Cited by 666
“…et al., 2000; Lanquillon et al., 2000; Maes et al., 1997a; Maes et al., 1995; MarquesDeak et al., 2007; Mikova et al., 2001; Yoshimura et al., 2009; Yoshimura et al., 2013), TNFα in 11 studies (Eller et al., 2008, 2009; Fornaro et al., 2013; Himmerich et al., 2006; Landmann et al., 1997;…”
InfluentialLiu, J. J., Wei, Y. B., Strawbridge, R., Bao, Y., Chang, S., Shi, L., Que, J., Gadad, B. S., Trivedi, M. H., Kelsoe, J. R., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0474-5 · Cited by 429
Role of Interleukin-6 in Depressive Disorder
Ting, E. Y.-C., Yang, A. C., & Tsai, S.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062194 · Cited by 385
Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis
Więdłocha, M., Marcinowicz, P., Krupa, R., Janoska-Jaździk, M., Janus, M., Dębowska, W., Mosiołek, A., Waszkiewicz, N., & Szulc, A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.026 · Cited by 233
Arteaga-Henríquez, G., Simon, M. S., Burger, B., Weidinger, E., Wijkhuijs, A., Arolt, V., Birkenhager, T. K., Musil, R., Müller, N., & Drexhage, H. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00458 · Cited by 215
Metadata
- Authors
- Yoshimura, R., Hori, H., Ikenouchi‐Sugita, A., Umene‐Nakano, W., Katsuki, A., Atake, K., & Nakamura, J.
- Venue
- Human Psychopharmacology: Clinical and Experimental
- Publisher
- Wiley
- Published
- 2013-06-30
- Volume
- 28
- Issue
- 5
- Pages
- 466-470
- ISSN
- 0885-6222 (ISSN-L)
- 1099-1077
- OpenAlex
- W1933084657
- Cited by
- 62
- References
- 12
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.